As of 2025-09-18, the Intrinsic Value of USANA Health Sciences Inc (USNA) is 66.81 USD. This USNA valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 30.18 USD, the upside of USANA Health Sciences Inc is 121.40%.
The range of the Intrinsic Value is 53.33 - 94.08 USD
Based on its market price of 30.18 USD and our intrinsic valuation, USANA Health Sciences Inc (USNA) is undervalued by 121.40%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 53.33 - 94.08 | 66.81 | 121.4% |
| DCF (Growth 10y) | 48.33 - 77.11 | 57.98 | 92.1% |
| DCF (EBITDA 5y) | 56.03 - 77.53 | 65.25 | 116.2% |
| DCF (EBITDA 10y) | 53.43 - 73.17 | 61.78 | 104.7% |
| Fair Value | 9.34 - 9.34 | 9.34 | -69.06% |
| P/E | 32.64 - 67.49 | 48.73 | 61.5% |
| EV/EBITDA | 35.46 - 74.62 | 54.00 | 78.9% |
| EPV | 19.46 - 22.90 | 21.18 | -29.8% |
| DDM - Stable | 15.36 - 39.62 | 27.49 | -8.9% |
| DDM - Multi | 32.51 - 65.61 | 43.52 | 44.2% |
| Market Cap (mil) | 551.39 |
| Beta | 0.97 |
| Outstanding shares (mil) | 18.27 |
| Enterprise Value (mil) | 400.05 |
| Market risk premium | 4.60% |
| Cost of Equity | 8.38% |
| Cost of Debt | 4.48% |
| WACC | 8.16% |